Association between anticoagulation strategy and quality of life in chronic hemodialysis patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 09 2023
13 09 2023
Historique:
received:
12
05
2023
accepted:
05
09
2023
medline:
15
9
2023
pubmed:
14
9
2023
entrez:
13
9
2023
Statut:
epublish
Résumé
Prevention of clotting in hemodialysis (HD) is a concern, but tools to monitor anticoagulation strategies as well as data on bleeding and its impact on quality of life (QoL) are scant. In this prospective longitudinal observational study, bleeding tendency in 70 HD patients was scored with ISTH-BAT and HAS-BLED at week 0, 4, and 8. Patient's limbs were visually scored for bruises and hematomas, and Quality of Life (QoL) was assessed using EQ5D-3L and Visual Analogue Scale (VAS) questionnaires. At week 0, the used hemodialyzer was scanned in a micro-CT scanner to quantify the number of patent fibers. Bleeding scores were 0 [0; 1] and 3 [2; 4] for ISTH-BAT and HAS-BLED, and visual scoring showed 2 [0; 4] bruises/hematomas. QoL was 0.85 [0.77; 1.00] for EQ5D and 70 [60; 80] for VAS. Fiber patency was 81 [70; 90]%, but was not associated with anticoagulation dose (p = 0.103). Patients in the highest tertile of anticoagulation dose had a worse VAS score (p = 0.027), and patients identified as having bleeding tendency by ISTH also had a worse VAS score (p = 0.010). This supports our postulate that in maintenance HD patients the current personal anticoagulation dose regimens may be too high, leading to more mainly minor bleeding that may negatively impact health related quality of life.
Identifiants
pubmed: 37704691
doi: 10.1038/s41598-023-42069-2
pii: 10.1038/s41598-023-42069-2
pmc: PMC10499826
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15105Informations de copyright
© 2023. Springer Nature Limited.
Références
Hellenic J Cardiol. 2019 Jan - Feb;60(1):3-10
pubmed: 29908761
Semin Dial. 2021 Mar;34(2):103-115
pubmed: 33135208
Sci Rep. 2022 Apr 5;12(1):5717
pubmed: 35383253
Chest. 2012 Feb;141(2 Suppl):e24S-e43S
pubmed: 22315264
PLoS One. 2019 Feb 20;14(2):e0212237
pubmed: 30785941
Nephrol Dial Transplant. 2017 Dec 1;32(12):1963-1966
pubmed: 29126280
Clin Kidney J. 2019 Dec 22;14(1):398-407
pubmed: 33564444
Med Care. 2009 Feb;47(2):255-61
pubmed: 19169128
Am J Kidney Dis. 2016 Sep;68(3):444-54
pubmed: 26968042
BMC Nephrol. 2017 Jun 7;18(1):187
pubmed: 28592259
BMC Nephrol. 2020 Jan 6;21(1):7
pubmed: 31906987
J Thromb Haemost. 2010 Sep;8(9):2063-5
pubmed: 20626619
Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
Nat Rev Nephrol. 2011 Jul 05;7(9):499-508
pubmed: 21727925
Artif Organs. 2019 Aug;43(8):756-763
pubmed: 30820962
BMC Nephrol. 2020 Mar 26;21(1):106
pubmed: 32216763
Sci Rep. 2018 Feb 8;8(1):2677
pubmed: 29422614
Kidney Int Rep. 2019 Jul 24;4(11):1538-1545
pubmed: 31890995